+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06877520

Early Feasibility Study of the Pivot Extend Device for Treating Severe Symptomatic Tricuspid Regurgitation with Long-Term Implantation and Safety Monitoring

Led by Tau-MEDICAL Co., Ltd. · Updated on 2025-04-11

7

Participants Needed

3

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

This clinical trial evaluates the safety and effectiveness of the investigational Pivot Extend medical device for treating severe and symptomatic tricuspid regurgitation TR. The study aims to monitor major adverse cardiac events MACEs and assess device and procedural success along with clinical outcomes over the long term in patients experiencing significant TR symptoms despite medical therapy. Participants will receive the Pivot Extend device, implanted via a transcatheter procedure guided by imaging. After implantation, participants stay under close observation for at least 24 hours to monitor vital signs and device stability. The device is intended for permanent placement with follow-up visits scheduled over a 12-month period to evaluate safety and clinical progress. Device removal may occur if adverse events arise or if the investigator deems it necessary. During the study, participants will attend scheduled visits at 1, 6, and 12 months after the procedure to assess clinical outcomes and procedural success. Researchers will collect data on heart function, symptoms, and any major cardiac events. Safety monitoring includes continuous observation initially post-implant and ongoing evaluation at follow-up visits. The total participation lasts at least one year, with detailed assessments to understand the devices impact on TR symptoms and patient health.

CONDITIONS

Brief Title

Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment

Research Team

M

Markus Reinthaler, MD, PhD

S

Seung-Whan Lee, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here